What is the main business of Actn3 Bioinformatics?

The main business activity of Actn3 Bioinformatics focuses on computer programming activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 23, 2018.

Where is the headquarters located?

The headquarters is located at: ul. 11 Listopada 187, 41-219 Sosnowiec.

Who is on the management board?

The management board consists of: Szymon Myrta (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $52,294 in 2024, which is an increase of 1.8% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $6,736, representing a multi-fold increase compared to 2023.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $32,539 in 2024, representing 73% of all operating expenses.

Actn3 Bioinformaticssp. z o.o.

Computer programming activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-08-23

Share capital

5 000,00 PLN

Activity description

Actn3 Bioinformatics is a company that provides professional bioinformatics services for the biotech and pharmaceutical industries, specializing in next-generation sequencing (NGS) analysis, R package development, and pipeline development. They offer end-to-end sequencing analysis, custom Bioconductor packages, and production-ready workflows, with a focus on regulatory compliance and reproducibility. With over 9 years of experience and 800+ samples analyzed, they deliver publication-ready insights and AI-powered solutions.

Registered address

ul. 11 Listopada 187/5, 41-219 Sosnowiec, Poland

Website

actn3.pl

Social media

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 34.25kMedianUSD 107.82kAverageUSD 1.88m

Net profit

This companyUSD -11.18kMedianUSD 2.13kAverageUSD 129.21k

Operating costs

This companyUSD 45.43kMedianUSD 100.58kAverageUSD 1.54m

Assets

This companyUSD 1.30kMedianUSD 73.78kAverageUSD 1.24m

Industry

Bank accounts

Registered as a VAT taxpayer on 2018-08-30. Active

mBank
11 1140 2004 0000 3302 7796 1084

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Szymon Myrta — President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Maria Dorota Myrta (67)	10	$135.06	10%
Szymon Myrta (38)	90	$1,215.56	90%

Szymon Myrta and Maria Dorota Myrta hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights
Szymon Myrta (38)	Shareholder of a limited liability company, 4500.0 PLN

Competitors

Name	Revenue	Website
Simmundisp. z o.o.	$85,415.15	simmundi.pl
DC Softwaresp. z o.o.	$84,121.27	dcsoftware.pl
Cybernes.Comsp. z o.o.	$75,887.40	cybernes.com
Cognitrek Corp.sp. z o.o.	$40,952.97	cognitrek.com
Nebulicsp. z o.o.	$41,243.25	nebulic.com
AprodataP.S.A.	$40,432.32	aprodata.com
Anzoniasp. z o.o.	$41,450.04	anzonia.pl
HealthnomicS.A.	$33,984.62	healthnomic.pl
Codoresp. z o.o.	$35,193.96	codore.pl
Calval.Plsp. z o.o.	$31,097.37	calval.pl

FAQ

Last updated: 2026-07-04